Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 3/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.42 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | USP7 | Q93009 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14722888 | 0.78 | NPBWR1 (0.49) | P2RX7CYP19A1RECQLALDH1A1HPGD | |
| SCHEMBL4361625 | 0.78 | P2RX7 (0.56) | P2RX7CYP19A1RECQLALDH1A1HPGD | |
| SCHEMBL21547789 | 0.77 | P2RX7 (0.47) | P2RX7CYP19A1RECQLALDH1A1HPGD | |
| SCHEMBL20745582 | 0.77 | NPBWR1 (0.51) | CYP19A1ALDH1A1ALOX15KDM4ESMN1; SMN2 | |
| SCHEMBL4365345 | 0.76 | TSHR (0.56) | P2RX7CYP19A1RECQLALDH1A1HPGD | |
| SCHEMBL3607562 | 0.76 | CYP19A1 (0.50) | P2RX7CYP19A1RECQLALDH1A1HPGD | |
| SCHEMBL568868 | 0.76 | KDM4E (0.72) | P2RX7CYP19A1RECQLALDH1A1HPGD | |
| SCHEMBL15675375 | 0.76 | CYP19A1 (0.50) | P2RX7CYP19A1RECQLALDH1A1HPGD | |
| SCHEMBL15711585 | 0.76 | P2RX7 (0.46) | P2RX7CYP19A1RECQLALDH1A1HPGD | |
| SCHEMBL27676261 | 0.76 | P2RX7 (0.50) | P2RX7CYP19A1RECQLALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4669612-B2 | — | — | 2011-04-13 | — | — | JP | claimed |
| US-20030109717-A1 | Preparation of substituted hydroxypyrazoles | GOTZ NORBERT (DE) | 2003-06-12 | — | — | US | claimed |
| JP-2002529454-A | — | — | 2002-09-10 | — | — | JP | claimed |
| EP-1127050-A1 | METHOD FOR PRODUCING 1-SUBSTITUTED 5-HYDROXYPYRAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-29 | — | — | EP | claimed |
| WO-2000027821-A1 | METHOD FOR PRODUCING 1-SUBSTITUTED 5-HYDROXYPYRAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-18 | — | — | WO | claimed |
| EP-1127050-B1 | METHOD FOR PRODUCING 1-SUBSTITUTED 5-HYDROXYPYRAZOLES | BASF SE (DE) | 2010-08-25 | — | — | EP | disclosed |
| EP-1127050-B1 | METHOD FOR PRODUCING 1-SUBSTITUTED 5-HYDROXYPYRAZOLES | BASF SE (DE) | 2010-08-25 | — | — | EP | disclosed |
| US-7614145-B2 | Method for manufacturing multilayer circuit board and resin base material | ZEON CORPORATION (JP) | 2009-11-10 | — | — | US | disclosed |
| CN-100496195-C | Mulitilayer circuit board, resin base material, and its production method | ZEON CORP (JP) | 2009-06-03 | — | — | CN | disclosed |
| US-20080217617-A1 | Thin Film Transistor, Wiring Board and Methods of Manufacturing the Same | ZEON CORPORATION (JP) | 2008-09-11 | — | — | US | disclosed |
| CN-100383278-C | Partial plating method, partially-plated resin base, method for manufacturing multilayer circuit board | ZEON CORP (JP) | 2008-04-23 | — | — | CN | disclosed |
| US-20050153059-A1 | Partial plating method, partially-plated resin base, method for manufacturing multilayered circuit board | ZEON CORPORATION (JP) | 2005-07-14 | — | — | US | disclosed |
| CN-1639384-A | Partial plating method, partially-plated resin base, method for manufacturing multilayer circuit board | ZEON CORP (JP) | 2005-07-13 | — | — | CN | disclosed |
| US-20040237295-A1 | Multilayer circuit board and resin base material, and its production method | ZEON CORPORATION (JP) | 2004-12-02 | — | — | US | disclosed |
| CN-1552174-A | Mulitilayer circuit board, resin base material, and its production method | �ձ�������ʽ���� | 2004-12-01 | — | — | CN | disclosed |
| US-6600071-B2 | Starting materials or intermediates and the cyclization of these under suitable reaction conditions to give compounds of the formula I. The intermediates of the formula II are novel. for argrochemicals | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-29 | — | — | US | disclosed |
| US-20030109717-A1 | Preparation of substituted hydroxypyrazoles | GOTZ NORBERT (DE) | 2003-06-12 | — | — | US | disclosed |
| US-6472538-B1 | HIGH YIELD COUPLING, HYDROGENATION AND CYCLIZATION TO FORM CHEMICAL INTERMEDIATES FOR HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-29 | — | — | US | disclosed |
| EP-1127050-A1 | METHOD FOR PRODUCING 1-SUBSTITUTED 5-HYDROXYPYRAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-29 | — | — | EP | disclosed |
| WO-2000027821-A1 | METHOD FOR PRODUCING 1-SUBSTITUTED 5-HYDROXYPYRAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109717-A1 | Preparation of substituted hydroxypyrazoles | CYC1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS | P2RX7 3547/4885CYP19A1 542/4885RECQL 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.